About Avisi Technologies
Avisi Technologies is a company based in Philadelphia (United States) founded in 2017 by Brandon Kao and Rui Jing Jiang.. Avisi Technologies has raised $5 million across 4 funding rounds from investors including Good Growth Capital, Ben Franklin Technology Partners and LSG Investments. Avisi Technologies operates in a competitive market with competitors including Glaukos, Novavax, SINTX, RevBio and Myra Vision, among others.
- Headquarter Philadelphia, United States
- Founders Brandon Kao, Rui Jing Jiang
-
Sectors
TechnologyHealthcare Chemicals & Materials
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Avisi Technologies, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$5 M (USD)
in 4 rounds
-
Latest Funding Round
$4 M (USD), Series A
Jan 23, 2023
-
Investors
Good Growth Capital
& 10 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Unlock access to complete
Board Team
11 people
Leadership Team
4 people
Software Development Team
2 people
Operations Team
2 people
Unlock access to complete
Funding Insights of Avisi Technologies
Avisi Technologies has successfully raised a total of $5M across 4 strategic funding rounds. The most recent funding activity was a Series A round of $4 million completed in January 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Series A — $4.0M
-
First Round
First Round
(01 Jul 2019)
- Investors Count 11
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2023 | Amount | Series A - Avisi Technologies | Valuation | Accanto Partners | |
| Jan, 2021 | Amount | Seed - Avisi Technologies | Valuation | MedTech Innovator |
|
| Sep, 2020 | Amount | Grant - Avisi Technologies | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Avisi Technologies
Avisi Technologies has secured backing from 11 investors, including venture fund and institutional investors. Prominent investors backing the company include Good Growth Capital, Ben Franklin Technology Partners and LSG Investments. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage investments are made in life sciences technologies.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
Investment and support are provided for Pennsylvania's tech-based companies.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Avisi Technologies
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Avisi Technologies
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Avisi Technologies Comparisons
Competitors of Avisi Technologies
Avisi Technologies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Glaukos, Novavax, SINTX, RevBio and Myra Vision, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of implants to treat glaucoma
|
|
| domain | founded_year | HQ Location |
Novel vaccines are developed using nanoparticle and matrix adjuvant technology.
|
|
| domain | founded_year | HQ Location |
Silicon nitride medical devices are manufactured for interbody fusion.
|
|
| domain | founded_year | HQ Location |
Synthetic adhesives for bone and dental repair are developed.
|
|
| domain | founded_year | HQ Location |
Nanotechnology-based devices for glaucoma treatment are developed.
|
|
| domain | founded_year | HQ Location |
Implantable device to relieve intraocular pressure in open angle glaucoma
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Avisi Technologies
Frequently Asked Questions about Avisi Technologies
When was Avisi Technologies founded?
Avisi Technologies was founded in 2017 and raised its 1st funding round 2 years after it was founded.
Where is Avisi Technologies located?
Avisi Technologies is headquartered in Philadelphia, United States. It is registered at Philadelphia, Pennsylvania, United States.
Who is the current CEO of Avisi Technologies?
Rui Jing Jiang is the current CEO of Avisi Technologies. They have also founded this company.
Is Avisi Technologies a funded company?
Avisi Technologies is a funded company, having raised a total of $5M across 4 funding rounds to date. The company's 1st funding round was a Grant of $1M, raised on Jul 01, 2019.
What does Avisi Technologies do?
Avisi Technologies was founded in 2017 in Philadelphia, United States. Nano-materials are developed by the company within the medical technology sector. An ultrathin nanoplate made of alumina is created as implant material for mid to late-stage glaucoma treatment. This work is conducted in collaboration with the University of Pennsylvania. A platform is provided to support these material developments and applications.
Who are the top competitors of Avisi Technologies?
Who are Avisi Technologies's investors?
Avisi Technologies has 11 investors. Key investors include Good Growth Capital, Ben Franklin Technology Partners, LSG Investments, Accanto Partners, and Quaker Capital Investments.